Pfizer Inc.
PFE
$25.06
-$0.73-2.83%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 09/28/2025 | 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 623.66% | -90.82% | 10,790.24% |
| Total Depreciation and Amortization | -- | -- | -9.73% | 2.35% | 1.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -120.48% | 523.61% | -2,592.86% |
| Change in Net Operating Assets | -- | -- | -165.58% | 232.88% | 124.87% |
| Cash from Operations | -- | -- | -65.26% | 0.10% | 476.98% |
| Capital Expenditure | -- | -- | 38.50% | -40.86% | -2.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 643.63% | 49.79% | -126.85% |
| Cash from Investing | -- | -- | 301.73% | 21.10% | -144.72% |
| Total Debt Issued | -- | -- | -- | -66.13% | -52.71% |
| Total Debt Repaid | -- | -- | 29.49% | 21.74% | 3.82% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -2.39% | 0.00% | 0.00% |
| Other Financing Activities | -- | -- | -2,442.86% | -133.33% | 90.48% |
| Cash from Financing | -- | -- | -2.21% | -10.31% | -88.53% |
| Foreign Exchange rate Adjustments | -- | -- | 75.86% | -422.22% | 150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -200.00% |
| Net Change in Cash | -- | -- | 931.11% | -255.17% | -91.55% |